CS Paper Radar

AI Model Design and Physician Liability

Shujie Luan, Shubhranshu Singh, Tinglong Dai

cs.AI econ.TH ·submitted 2026-08-12 21:08 UTC · v2

Abstract

Clinical algorithms can perform differently across patient groups, a concern that grows as these algorithms increasingly take the form of artificial intelligence (AI) models. In the United States, a 2024 federal rule bars healthcare providers that receive federal funds from discriminating through their use of clinical algorithms, which exposes them to liability when such use disadvantages a protected patient group. We examine how such liability considerations reshape (i) an AI firm's model design decisions that drive group-specific accuracy and (ii) a physician's decisions to use AI in healthcare delivery. The firm designs an AI model for two patient groups, and improving accuracy for the disadvantaged group is more costly. The physician (who remains the accountable decision maker) then decides whether to consult AI, weighing the reduction in clinical uncertainty against expected liability exposure when AI errors disproportionately affect the disadvantaged group. We find that this liability can induce disparate use of AI: the physician may reduce AI use overall and, over an intermediate range of liability, rely on AI less for disadvantaged patients. The effect is non-monotone. As liability increases, the physician's use of AI for disadvantaged patients first declines, then rises as the firm reallocates investment toward reducing disparity or switches to an equal-accuracy design. Mandating equal algorithmic accuracy across patient groups can then inadvertently harm both groups, because a uniform accuracy requirement distorts the firm's investment incentives and the physician's equilibrium AI-use decisions.

Comment
Forthcoming in Management Science. 66 pages, 8 figures, 5 tables; includes online appendix (pp. oa1-oa15)

Closest papers

Nearest neighbours by meaning across the whole index.

"It's still 100% on me": Designing AI Tools for the Intersection of Physicians' Care and Legal Infrastructures

cs.HC ·2026-11-11 ·Gennie Mansi, Julia Kim, Lynn Dombrowski, Mark Riedl, Naveena Karusala
similarity 0.69
Abstract · 27 pages, 0 figures

Laws and regulations deeply shape physicians' workflows and impact how they incorporate AI-based decision support tools to care for patients. Despite calls to comply with legal standards, many AI-based decision support tools have not transitioned well to clinical settings. The medical community remains concerned about their legal liability, risks to patients, and limited clinical value of such tools. To better understand how to address these concerns in the design of AI tools for clinical decision-making, we conducted 19 interviews with physicians in the U.S. We used scenario-based design to investigate physicians' legal concerns in the context of an AI-based drug recommendation tool. Drawing on the ethics of care, we surface connections between physicians' care and the healthcare laws and regulations that deeply shape their information needs. We describe how physicians wanted to use the tool in individual and collective practices to care for themselves, their patients, their colleagues, work institution, and even the broader medical profession. We discuss how the design of AI-based decision support tools can present legal ambiguities that would prevent their caring actions and lead to non-use of the AI tool. Through our work, we contribute to responsible AI development in healthcare. Our analysis illuminates why and how certain kinds of information reduce legal ambiguity and support physicians' care when using AI-based decision support tools. We contribute an understanding of how to help physicians navigate legal liability and draw implications for grounding AI tools' designs in their care.

0.38

A Sociotechnical Review of Algorithms in Health Systems: Technical, Cost, and Human-Centered Considerations

cs.HC ·2026-09-18 ·Victoria Chui, Kelly McConvey, Shion Guha
similarity 0.62
Abstract

Artificial intelligence (AI) applications in healthcare are becoming increasingly prevalent, to assist health systems, providers, and patients with tasks such as decision-making, risk prediction, and diagnosis. This increasing computational potential brings AI applications to the forefront of workplace decision making, often without full consideration of subsequent computational, organizational, and social costs. These applications are leveraged to reduce healthcare costs and increase efficiency of daily tasks, with model-related costs being considered at varying levels of granularity. To understand these trends, we critically analyze 114 papers to examine how cost-aware AI models have been developed for health systems. We explore the data, method, and outcome choices of these models, as well as their intersection with cost and human-centered concerns, highlighting the gaps in rigorous sociotechnical model design. From these trends, we define model costs and subsequent dimensions, presenting insight into those studies reporting financial, computational, organizational and/or social measures. Further, we critique the benefits and challenges of evaluating model-related costs and sustainability concerns when developing AI models for health systems.

0.23

Fairness or Fallacy? Mapping the Landscape of AI Bias in Disease Detection

cs.AI ·2026-10-19 ·Ghulam Mudassir, Hameed Ullah Khan, Ahmad Sami Al-Shamayleh, Muhammad Faizan Khan, Muhammad Muqtasid +2 more
similarity 0.62
Abstract

Artificial intelligence (AI) has several transformative effects on healthcare, like to facilitate clinicians in disease detection and to manage patient care with enhanced precision. Due to the increasing complexity of medical data and the growing volume of diagnostic images, the substantial computational power needed to process such information creates both opportunities and challenges. To accomplish this objective, numerous methodologies have been proposed to integrate AI into disease detection systems. All these methodologies consider different aspects of clinical diagnosis, considering key parameters such as the type of AI model employed, the nature of input data, and the population demographics being analysed. In this paper, we review different state-of-the-art techniques which have been proposed for various areas of disease detection, specifically focusing on bias identification and mitigation. The proposed solutions are distinguished based on the type of input data they utilize, the architecture of model, and type of bias (algorithmic bias, demographic bias, model bias, and deployment bias). The time frame chosen to filter out relevant studies is between 2015 and 2026. Eventually, we review 23 related articles out of 64,389 analyzed from seven different digital libraries. The obtained results guide us to reach a conclusion with respect to state-of-the-art selected studies. Furthermore, these results reveal significant research gaps that can assist researchers in addressing AI-related bias in medical diagnosis. By prioritizing explainability, data diversity, and fairness in algorithmic design, as well as equitable access for affected patient populations, they can utilize available healthcare resources more effectively.

0.32

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.61
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

Whose doctor does the AI recommend? An algorithm audit of reputation and demographic signals in large language model-assisted physician choice

cs.CY cs.AIcs.CL ·2026-08-14 ·Syeda Anshrah Gillani, Mirza Samad Ahmed Baig
similarity 0.60
Abstract · 26 pages, 9 figures, 10 tables

Patients increasingly ask large language model (LLM) assistants which doctor to see, making these systems AI infomediaries: algorithms that intermediate one person's choice among other people and thereby decide, silently and at scale, which physicians become visible. We report a prespecified randomized algorithm audit of what causally moves those recommendations. Seven models (six open-weight; gpt-4o-mini) each chose among five synthetic family-medicine physician cards whose attributes were independently randomized across 3,024 choice sets, three patient personas, nine prompt paraphrases and nine experimental arms, yielding 40,068 scored responses; gender and ethnicity were signaled through names following correspondence-audit methodology. Reputation signals dominate: raising a rating from 3.9 to 4.7 increases choice probability by 31.4 percentage points (pp), and raising the fee from $90 to $190 lowers it by 20.0 pp. Demographic parity is rejected, but not in the direction human audit studies predict: female-signaled names gain 2.5 pp, and Hispanic-, South-Asian- and Black-signaled names gain 1.3-2.9 pp over White-signaled names, tilts worth $7-$14 per visit in fee-equivalent terms, and a content-free first-listed position is worth $11. Yet models mentioned gender or ethnicity in at most 0.03% of their stated reasons and abstained in 0.39% of trials, so these effects are invisible in the models' own explanations, and transparency obligations relying on model self-report would not detect them. One reasoning model failed the prespecified auditability gate outright. The frozen design makes the audit repeatable: any new model can be assessed against identical stimuli, making recurring behavioural audit, rather than self-reported explanation, the monitoring technology fit for purpose.

0.10

Algorithmic Bias from the Perspectives of Healthcare Professionals

cs.AI ·2026-10-27 ·Jennifer Xu, Tamara Babaian
publishedsurveyhighly cited similarity 0.60
Abstract · 12 pages

This paper focuses on algorithmic bias of machine learning and artificial intelligence applications in healthcare information systems. Based on the quantitative data and qualitative comments from a survey and interviews with healthcare professionals, who have different job roles (e.g., clinical vs. administrative), this study provides findings about the relationships between algorithmic bias, perceived fairness, and the intended acceptance and adoption of ML algorithms and algorithm generated outcomes. The results suggest that the opinions of healthcare professionals toward the causes of algorithmic bias, the criteria of algorithm assessment, the perceived fairness, and bias mitigation approaches may vary depending on their job roles, perspectives, tasks, and the algorithm characteristics. More research is needed to investigate algorithmic bias to ensure fairness and equality in healthcare.

0.55

Indirect Influences of Artificial Intelligence Advice on Complex Sepsis Treatment Decisions

cs.HC cs.AIq-bio.QM ·2026-10-16 ·Venkatesh Sivaraman, Joel Levin, Eric P. Mason, Victor Talisa, Suchi Saria +4 more
similarity 0.59
Abstract

Sepsis is a major public health concern, and many sepsis patients die due to ineffective hemodynamic management. Artificial intelligence could support hemodynamic decisions, particularly in complex cases where conflicting information and comorbidities drive uncertainty and practice variation. However, these systems' real-world value depends on not just accuracy, but how they influence the quality of clinician decisions. We first retrospectively evaluated an AI system's recommendations in 6,928 sepsis patients, finding that they improved upon the original providers' decisions overall but had significantly worse performance in complex cases. We then conducted a pre-registered experiment with 228 US critical care physicians to test their use of this imperfect advice in six complex treatment decisions, using one of three advice types designed to vary reasoning autonomy. Participants given simple model recommendations overcame poor advice, choosing optimal treatments in 56.3% of decisions compared to 31.8% if they had always followed the recommendations. They also made significantly better decisions than those receiving a less prescriptive advice type (42.9%). Physicians selectively adapted and improved weak advice, likely because it prompted them to reconsider their assessment. Our findings suggest that improving sepsis care decisions with AI may require accounting for these indirect influences resulting from human-AI collaborative reasoning.

0.26

When Clinical Judgment Becomes a Predictive Shortcut: Two Questions Clinical AI Must Answer Before Deployment

cs.AI ·2026-09-22 ·Jing Yang, Long R. Jiao, Zongjiu Zhang, Xiujun Cai
similarity 0.59
Abstract · 27 pages, 1 figure, 3 tables, 1 box; includes Multimedia Appendix 1

Clinical AI can predict outcomes using information generated by existing clinical judgment. Such performance alone cannot establish usefulness before recognition or across care processes. We propose evidence requirements matched to intended use and information conditions, with additional state-reference and proxy-relative timing tests for stronger recognition claims. This framework helps hospitals assess whether the conditions supporting performance hold when assistance is most needed. These questions remain outside current evaluation practice leakage checks, overall predictive performance, and external validation do not address them; the framework makes them explicit and specifies the direct evidence required to answer them.

0.19